User profiles for "author:Daniel Baumhoer"

Prof. Dr. med. Daniel Baumhoer

Knochentumor-Referenzzentrum und DÖSAK Referenzregister, Institut für Medizinische …
Verified email at pathologie.unispital-basel.ch
Cited by 11847

[HTML][HTML] The landscape of genomic alterations across childhood cancers

SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter… - Nature, 2018 - nature.com
Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …

An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing

D Baumhoer, F Amary… - Genes, Chromosomes …, 2019 - Wiley Online Library
The last decade has seen the majority of primary bone tumor subtypes become defined by
molecular genetic alteration. Examples include giant cell tumour of bone (H3F3A p. G34W) …

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

S Behjati, PS Tarpey, N Presneau, S Scheipl, N Pillay… - Nature …, 2013 - nature.com
It is recognized that some mutated cancer genes contribute to the development of many
cancer types, whereas others are cancer type specific. For genes that are mutated in …

[HTML][HTML] Sarcoma classification by DNA methylation profiling

C Koelsche, D Schrimpf, D Stichel, M Sill… - Nature …, 2021 - nature.com
Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents and
children. They represent a morphologically heterogeneous class of tumours and some …

Diagnostic challenges and future perspectives in fracture-related infection

M Morgenstern, R Kühl, H Eckardt, Y Acklin, B Stanic… - Injury, 2018 - Elsevier
Fracture-related infection (FRI) is one of the most challenging complications in orthopaedic
trauma surgery. It has severe consequences for patients and an important socio-economic …

Odontogenic myxoma: diagnostic and therapeutic challenges in paediatric and adult patients–a case series and review of the literature

K Kansy, P Juergens, Z Krol, M Paulussen… - Journal of Cranio …, 2012 - Elsevier
INTRODUCTION: Odontogenic myxomas are benign but locally invasive tumours originating
from primordial mesenchymal tooth forming tissues which do not metastasise. We present a …

[HTML][HTML] Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade …

SS Bielack, S Smeland, JS Whelan… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose EURAMOS-1, an international randomized controlled trial, investigated
maintenance therapy with pegylated interferon alfa-2b (IFN-α-2b) in patients whose …

[HTML][HTML] Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

M Kovac, C Blattmann, S Ribi, J Smida… - Nature …, 2015 - nature.com
Osteosarcomas are aggressive bone tumours with a high degree of genetic heterogeneity,
which has historically complicated driver gene discovery. Here we sequence exomes of 31 …

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples

D Baumhoer, L Tornillo, S Stadlmann… - American journal of …, 2008 - academic.oup.com
Several studies have shown that glypican 3 (GPC3) could be a useful diagnostic marker for
hepatocellular carcinoma (HCC) and for differentiating HCC from nonneoplastic and …

Recurrent PTPRB and PLCG1 mutations in angiosarcoma

S Behjati, PS Tarpey, H Sheldon, I Martincorena… - Nature …, 2014 - nature.com
Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to
ionizing radiation or chronic lymphoedema. Previous work has identified aberrant …